Cutaneous estradiol permeation, penetration and metabolism in pig and man

Skin Pharmacology and Physiology

Volumn 18, Issue 1, 2005, Pages 27-35

  Mahmoud, A ^a   Haberland, A ^a   Durrfeld M ^a   Heydeck, D ^a   Wagner, S ^a   Schafer Korting M ^a  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

Alternative methods; Estrogen metabolism; Perfused porcine forelimb; Reconstructed epidermis; Skin penetration

Indexed keywords

ALCOHOL; DRUG VEHICLE; ESTRADIOL; ESTRONE;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG METABOLISM; DRUG PENETRATION; DRUG UPTAKE; EPIDERMIS; ESTRADIOL BLOOD LEVEL; ESTRONE BLOOD LEVEL; FEMALE; FORELIMB; GEL; HORMONE METABOLISM; HORMONE SUBSTITUTION; LIMB PERFUSION; NONHUMAN; PREDICTION; PRIORITY JOURNAL; SKIN CELL; SKIN PENETRATION; SKIN PERMEABILITY; SWINE; WOUND HEALING;

ADMINISTRATION, CUTANEOUS; ANIMALS; DRUG DELIVERY SYSTEMS; EPIDERMIS; ESTRADIOL; ESTRONE; FEMALE; FORELIMB; GELS; HUMANS; MODELS, BIOLOGICAL; PERFUSION; PERMEABILITY; RADIOIMMUNOASSAY; SKIN ABSORPTION; SOLVENTS; SWINE; TIME FACTORS;

EID: 11444258898     PISSN: 16605527     EISSN: None     Source Type: Journal    
DOI: 10.1159/000081683     Document Type: Article

References (28)

1. Wassertheil-Smoller S, Hendrix SL, Limacher M, Heiss G, Kooperberg C, Baird A, Kotchen T, Curb JD, Black H, Rossouw JE, Aragaki A, Safford M, Stein E, Laowattana S, Mysiw WJ: Effect of estrogen plus progestin on stroke in postmenopausal women: The Women's Health Initiative, a randomized trial. JAMA 2003;289:2673-2684.
2. Davison S, Davis SR: Hormone replacement therapy: Current controversies. Clin Endocrinol (Oxf) 2003;58:249-261.
3. Lindoff C, Peterson F, Lecander I, Martinsson G, Astedt B: Transdermal estrogen replacement therapy: Beneficial effects on hemostatic risk factors for cardiovascular disease. Maturitas 1996;24:43-50.
4. Vehkavaara S, Silveira A, Hakala-Ala-Pietila T, Virkamaki A, Hovatta O, Hamsten A, Taskinen MR, Yki-Jarvinen H: Effects of oral and transdermal estrogen replacement therapy on markers of coagulation, fibrinolysis, inflammation and serum lipids and lipoproteins in postmenopausal women. Thromb Haemost 2001;85:619-625.
5. Decensi A, Omodei U, Robertson C, Bonanni B, Guerrieri-Gonzaga A, Ramazzotto F, Johansson H, Mora S, Sandri MT, Cazzaniga M, Franchi M, Pecorelli S: Effect of transdermal estradiol and oral conjugated estrogen on C-reactive protein in retinoid-placebo trial in healthy women. Circulation 2002;106:1224-1228.
6. Calvin M: Oestrogens and wound healing. Maturitas 2000;34:195-210.
7. Ashcroft GS, Greenwell-Wild T, Horan MA, Wahl SM, Ferguson MW: Topical estrogen accelerates cutaneous wound healing in aged humans associated with an altered inflammatory response. Am J Pathol 1999;155:1137-1146.
8. Kligman AM: Skin permeability: Dermatologic aspects of transdermal drug delivery. Am Heart J 1984;108:200-206.
9. Rougier A, Dupuis D, Lotte C, Roguet R, Schaefer H: In vivo correlation between stratum corneum reservoir function and percutaneous absorption. J Invest Dermatol 1983;81:275-278.
10. Setnikar I, Rovati LC, Vens-Cappell B, Hilgenstock C: Pharmacokinetics of estradiol and of estrone during repeated transdermal or oral administration of estradiol. Arzneimittelforschung 1996;46:766-773.
11. Nachtigall LE, Raju U, Banerjee S, Wan L, Levitz M: Serum estradiol-binding profiles in postmenopausal women undergoing three common estrogen replacement therapies: Associations with sex hormone-binding globulin, estradiol, and estrone levels. Menopause 2000;7:243-250.
12. Slater CC, Hodis HN, Mack WJ, Shoupe D, Paulson RJ, Stanczyk FZ: Markedly elevated levels of estrone sulfate after long-term oral, but not transdermal, administration of estradiol in postmenopausal women. Menopause 2001;8:200-203.
13. De Lignières B, Basdevant A, Thomas G, Thalabard JC, Mercier-Bodard C, Conard J, Guyène TT, Mairon N, Corvol P, Guy-Grand B, et al: Biological effects of estradiol-17 beta in postmenopausal women: Oral versus percutaneous administration. J Clin Endocrinol Metab 1986;62:536-541.
14. Setnikar I, Rovati LC, Thebault JJ, Guillaume M, Mignot A, Renoux A, Gualano V: Pharmacokinetics of estradiol and of estrone during application of three strengths of an estradiol transdermal patch with active matrix. Arzneimittelforschung 1997;47:859-865.
15. Järvinen A, Nykänen S, Paasiniemi L: Absorption and bioavailability of oestradiol from a gel, a patch and a tablet. Maturitas 1999;32:103-113.
16. Kanikkannan N, Kandimalla K, Lamba SS, Singh M: Structure-activity relationship of chemical penetration enhancers in transdermal drug delivery. Curr Med Chem 2000;7:593-608.
17. Altenburger R, Kissel T: Biotransformation of estradiol in the human keratinocyte cell line HaCaT: Metabolism kinetics and the inhibitory effect of ethanol. Pharm Res 1998;15:1684-1689.
18. Santos Maia C, Mehnert W, Schaller M, Korting HC, Gysler A, Haberland A, Schäfer-Korting M: Drug targeting by solid lipid nanoparticles for dermal use. J Drug Target 2002;10:489-495.
19. Haberland A, Santos Maia C, Jores K, Dürrfeld M, Mehnert W, Schimke I, Christ B, Schäfer-Korting M: Albumin effects on drug absorption and metabolism in reconstructed epidermis and excised pig skin. Altex 2003;20:3-9.
20. Wagner SM, Nogueira AC, Paul M, Heydeck D, Klug S, Christ B: The isolated normothermic hemoperfused porcine forelimb as a test system for transdermal absorption studies. J Artif Organs 2003;6:183-191.
21. Roberts KD, Rochefort JG, Bleau G, Chapdelaine A: Plasma estrone sulfate levels in postmenopausal women. Steroids 1980;35:179-187.
22. Gysler A, Lange K, Korting HC, Schäfer-Korting M: Prednicarbate biotransformation in human foreskin keratinocytes and fibroblasts. Pharm Res 1997;14:793-797.
23. Rohr UD, Altenburger R, Kissel T: Pharmacokinetics of the transdermal reservoir membrane system delivering beta-estradiol: In vitro/in vivo correlation. Pharm Res 1998;15:877-882.
24. Bando H, Mohri S, Yamashita F, Takakura Y, Hashida M: Effects of skin metabolism on percutaneous penetration of lipophilic drugs. J Pharm Sci 1997;86:759-761.
25. OECD: Skin absorption: In Vitro Method (Technical Guideline 428). Paris, OECD, 2004.
26. Lotte C, Patouillet C, Zanini M, Messager A, Roguet R: Permeation and skin absorption: Reproducibility of various industrial reconstructed human skin models. Skin Pharmacol Appl Skin Physiol 2002;15(suppl 1):18-30.
27. Paoletti AM, Pilia I, Nannipieri F, Bigini C, Melis GB: Comparison of pharmacokinetic profiles of a 17 beta-estradiol gel 0.6 mg/g (Gelestra) with a transdermal delivery system (Estraderm TTS 50) in postmenopausal women at steady state. Maturitas 2001;40:203-209.
28. Steffens RJ, Hayes MJ, Powell M, Berner B, Morgan J, Joshi C, Guernsey K, Good WR: The cutaneous metabolism of nitroglycerin. Proc Int Symp Control Rel Bioactive Mater 1992;19:236-237.